Advances in stroke neuroprotection: hyperoxia and beyond.

Refinements in patient selection, improved methods of drug delivery, use of more clinically relevant animal stroke models, and the use of combination therapies that target the entire neurovascular unit make stroke neuroprotection an achievable goal. This article provides an overview of the major mechanisms of neuronal injury and the status of neuroprotective drug trials and reviews emerging strategies for treatment of acute ischemic stroke. Advances in the fields of stem cell transplantation, stroke recovery, molecular neuroimaging, genomics, and proteomics will provide new therapeutic avenues in the near future. These and other developments over the past decade raise expectations that successful stroke neuroprotection is imminent.

[1]  F. Buonanno,et al.  A pilot study of drug-induced hypertension for treatment of acute stroke , 2001, Neurology.

[2]  F. Cheng,et al.  Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. , 2002, Life sciences.

[3]  V. Perry,et al.  Monocyte Chemoattractant Protein-1 Deficiency is Protective in a Murine Stroke Model , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  P. Chan Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  S. Warach New imaging strategies for patient selection for thrombolytic and neuroprotective therapies , 2001, Neurology.

[6]  L. Nowak,et al.  Magnesium gates glutamate-activated channels in mouse central neurones , 1984, Nature.

[7]  E. Lo,et al.  Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats , 2002, Stroke.

[8]  Mathias Hoehn-Berlage,et al.  Potassium-Induced Cortical Spreading Depressions during Focal Cerebral Ischemia in Rats: Contribution to Lesion Growth Assessed by Diffusion-Weighted NMR and Biochemical Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  B R Rosen,et al.  Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. , 1999, Radiology.

[10]  K. Rajamani,et al.  Stroke precipitated by moderate blood pressure reduction. , 2000, The Journal of emergency medicine.

[11]  J. Grotta,et al.  Lubeluzole in Acute Ischemic Stroke Treatment: A Double-Blind Study With an 8-Hour Inclusion Window Comparing a 10-mg Daily Dose of Lubeluzole With Placebo , 2000, Stroke.

[12]  G. Feuerstein,et al.  Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality. , 1987, Stroke.

[13]  R. Busto,et al.  Human Albumin Therapy of Acute Ischemic Stroke: Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window , 2001, Stroke.

[14]  D. Holtzman,et al.  Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury* , 2002, The Journal of Biological Chemistry.

[15]  Yi Li,et al.  Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke , 2003, Annals of neurology.

[16]  G. Hankey,et al.  Clomethiazole Acute Stroke Study in Ischemic Stroke (CLASS-I): Final Results , 2002, Stroke.

[17]  Marcel Leist,et al.  Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.

[18]  D. Krieger,et al.  Therapeutic Hypothermia for Acute Ischemic Stroke: What Do Laboratory Studies Teach Us? , 2004, Stroke.

[19]  Guo-Yuan Yang,et al.  Reduced Ischemic Brain Injury in Interleukin-1β Converting Enzyme—Deficient Mice , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  Christopher Putman,et al.  Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated With Intra-Arterial Thrombolysis:: Prediction of Final Infarct Volume and Clinical Outcome , 2001, Stroke.

[21]  Tao Yang,et al.  Glycoprotein IIb/IIIa Antagonist, Murine 7E3 F(ab′)2, and Tissue Plasminogen Activator in Focal Ischemia: Evaluation of Efficacy and Risk of Hemorrhage with Combination Therapy , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  H. Fukasawa,et al.  Therapeutic effects of hyperbaric oxygenation on acute focal cerebral ischemia in rats. , 1990, Surgical neurology.

[23]  B. Meldrum,et al.  Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarizations in focal cerebral ischemia. , 2000, Stroke.

[24]  D. Choi,et al.  Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia , 1996, Brain Research.

[25]  F. Welsh,et al.  Postischemic Hypothermia Fails to Reduce Ischemic Injury in Gerbil Hippocampus , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  H. Weiss,et al.  Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. , 1990, Archives internationales de pharmacodynamie et de therapie.

[27]  D. Liebeskind,et al.  Trends in Acute Ischemic Stroke Trials Through the 20th Century , 2001, Stroke.

[28]  J. Ulatowski,et al.  A Pilot Randomized Trial of Induced Blood Pressure Elevation: Effects on Function and Focal Perfusion in Acute and Subacute Stroke , 2003, Cerebrovascular Diseases.

[29]  Jun Chen,et al.  Programmed Cell Death in Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  B. Siesjö,et al.  Thresholds in cerebral ischemia - the ischemic penumbra. , 1981, Stroke.

[31]  G. Schlaug,et al.  The ischemic penumbra: operationally defined by diffusion and perfusion MRI. , 1999, Neurology.

[32]  Á. Chamorro Role of Inflammation in Stroke and Atherothrombosis , 2004, Cerebrovascular Diseases.

[33]  M. Moskowitz,et al.  Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia , 2001, British journal of pharmacology.

[34]  M. Ross,et al.  Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  John H. Zhang,et al.  Dual effect of HBO on cerebral infarction in MCAO rats. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  J. Martí-Fàbregas,et al.  Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins , 2004, Stroke.

[37]  R. R. Smith,et al.  Hyperbaric oxygen and cerebral infarction in the gerbil. , 1987, Surgical neurology.

[38]  P. Stys,et al.  Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  S. Warach,et al.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.

[40]  D. Corbett,et al.  Persistent Neuroprotection with Prolonged Postischemic Hypothermia in Adult Rats Subjected to Transient Middle Cerebral Artery Occlusion , 2000, Experimental Neurology.

[41]  R. Silbergleit,et al.  Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity , 2003, Brain Research.

[42]  P. Adeleine,et al.  Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. , 1995, Stroke.

[43]  E. Lo,et al.  Induction of Caspase-Mediated Cell Death by Matrix Metalloproteinases in Cerebral Endothelial Cells after Hypoxia—Reoxygenation , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  A E Hillis,et al.  Restoring blood pressure reperfused Wernicke’s area and improved language , 2001, Neurology.

[45]  S. Mayer,et al.  Effect of Prior Statin Use on Functional Outcome and Delayed Vasospasm after Acute Aneurysmal Subarachnoid Hemorrhage: A Matched Controlled Cohort Study , 2005, Neurosurgery.

[46]  F. Nicoletti,et al.  Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective Drugs , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  Günther Deuschl,et al.  Therapeutic Window for Use of Hyperbaric Oxygenation in Focal Transient Ischemia in Rats , 2004, Stroke.

[48]  Klaas Nicolay,et al.  Correlation between tissue depolarizations and damage in focal ischemic rat brain 1 Published on the World Wide Web on 12 July 1999. 1 , 1999, Brain Research.

[49]  D. W. Beck,et al.  Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. , 1982, Neurosurgery.

[50]  John Whitehead,et al.  Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial , 2000, The Lancet.

[51]  P. Lyden,et al.  Synergistic Combinatorial Stroke Therapy: A Quantal Bioassay of a GABA Agonist and a Glutamate Antagonist , 2000, Experimental Neurology.

[52]  K. Asplund,et al.  Does Pretreatment With Statins Improve Clinical Outcome After Stroke?: A Pilot Case-Referent Study , 2001, Stroke.

[53]  B. Lin,et al.  Detection of Free Radical Activity During Transient Global Ischemia and Recirculation: Effects of Intraischemic Brain Temperature Modulation , 1995, Journal of neurochemistry.

[54]  Thomas Benner,et al.  A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic Stroke , 2005, Stroke.

[55]  P. Bernardi,et al.  A mitochondrial perspective on cell death. , 2001, Trends in biochemical sciences.

[56]  M. Fisher,et al.  A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. , 2000, Acta neurochirurgica. Supplement.

[57]  G. Mies,et al.  Repeated Negative DC Deflections in Rat Cortex following Middle Cerebral Artery Occlusion are Abolished by MK-801: Effect on Volume of Ischemic Injury , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[58]  E. Lo,et al.  Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia , 2005, Annals of neurology.

[59]  W. Hacke,et al.  Tolerability of NXY-059 at Higher Target Concentrations in Patients With Acute Stroke , 2003, Stroke.

[60]  Tatsuro Mori,et al.  Effects of Normobaric Hyperoxia in a Rat Model of Focal Cerebral Ischemia—Reperfusion , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[61]  B. Cheung,et al.  Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. , 2004, British journal of clinical pharmacology.

[62]  M. A. Jacobs,et al.  Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke , 2004, Neuroradiology.

[63]  S. Lipton,et al.  Excitotoxins in Neuronal Apoptosis and Necrosis , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  K. Takakura,et al.  Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. , 1998, Stroke.

[65]  Stephen Rose,et al.  Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in stroke , 2002, Annals of neurology.

[66]  D. J. Cole,et al.  Focal Cerebral Ischemia in Rats: Effects of Induced Hypertension, during Reperfusion, on CBF , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[67]  Jean-Philippe Thiran,et al.  Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients , 2002, Annals of neurology.

[68]  Seong-Gi Kim,et al.  Effect of hyperoxia, hypercapnia, and hypoxia on cerebral interstitial oxygen tension and cerebral blood flow , 2001, Magnetic resonance in medicine.

[69]  U. Laufs,et al.  Pleiotropic effects of statins. - Basic research and clinical perspectives -. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[70]  N. Plesnila,et al.  Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Busto,et al.  Lipid Peroxidation In Vivo Induced by Reversible Global Ischemia in Rat Brain , 1984, Journal of neurochemistry.

[72]  Enlimomab Acute Stroke Trial Investigators Use of anti-ICAM-1 therapy in ischemic stroke , 2001, Neurology.

[73]  K. Arai,et al.  Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.

[74]  T. Olsen,et al.  Feasibility and Safety of Inducing Modest Hypothermia in Awake Patients With Acute Stroke Through Surface Cooling: A Case-Control Study: The Copenhagen Stroke Study , 2000, Stroke.

[75]  C. Edenius,et al.  Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke , 2002, European Journal of Clinical Pharmacology.

[76]  Fuhai Li,et al.  Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. , 1999, Stroke.

[77]  W. Koroshetz,et al.  SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage , 2005, Neurology.

[78]  M. Endres,et al.  Withdrawal of Statin Treatment Abrogates Stroke Protection in Mice , 2003, Stroke.

[79]  P. Nicotera,et al.  Energy Requirement for Caspase Activation and Neuronal Cell Death , 2000, Brain pathology.

[80]  T. Oury,et al.  Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia , 1999, Neuroscience.

[81]  L. Wilkins Clinical Trial of Nimodipine in Acute Ischemic Stroke , 1992 .

[82]  J. Seylaz,et al.  Reduction of Infarct Volume by Magnesium after Middle Cerebral Artery Occlusion in Rats , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  J. Zivin,et al.  Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. , 1991, Archives of neurology.

[84]  A Gregory Sorensen,et al.  Assessing tissue viability with MR diffusion and perfusion imaging. , 2003, AJNR. American journal of neuroradiology.

[85]  Fangyi Zhang,et al.  Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.

[86]  N. Noshita,et al.  Manganese Superoxide Dismutase Deficiency Exacerbates Cerebral Infarction After Focal Cerebral Ischemia/Reperfusion in Mice: Implications for the Production and Role of Superoxide Radicals , 2002, Stroke.

[87]  John H. Zhang,et al.  Effect of hyperbaric oxygen on apoptosis in neonatal hypoxia-ischemia rat model. , 2003, Journal of applied physiology.

[88]  P. Lyden,et al.  The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator–treated stroke (CLASS-T) , 2001, Neurology.

[89]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[90]  S. Heiland,et al.  Hyperbaric oxygen induces rapid protection against focal cerebral ischemia , 2005, Brain Research.

[91]  N. Lassen,et al.  TREATMENT OF FOCAL CEREBRAL ISCHEMIA WITH HYPERBARIC OXYGEN , 1964 .

[92]  G. Feuerstein,et al.  Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia , 2000, Brain pathology.

[93]  A. Cross,et al.  Effect of NXY‐059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window , 2002, British journal of pharmacology.

[94]  C. Sommer,et al.  Neuroprotection by Hyperbaric Oxygenation After Experimental Focal Cerebral Ischemia Monitored by MRI , 2004, Stroke.

[95]  M. Moskowitz,et al.  Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. , 2001, Stroke.

[96]  L Persson,et al.  The Effect of MK-801 on Cortical Spreading Depression in the Penumbral Zone following Focal Ischaemia in the Rat , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[97]  Michael Holzer,et al.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest , 2002 .

[98]  G. Fiskum Mitochondrial participation in ischemic and traumatic neural cell death. , 2000, Journal of neurotrauma.

[99]  R. Crowell,et al.  Beneficial effects of induced hypertension on experimental stroke in awake monkeys. , 1984, Journal of neurosurgery.

[100]  N. Wahlgren,et al.  Clomethiazole Acute Stroke Study (CLASS) Results of a Randomized, Controlled Trial of Clomethiazole Versus Placebo in 1360 Acute Stroke Patients , 1998 .

[101]  A. Shuaib,et al.  Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate , 2000, Neuropharmacology.

[102]  F. Jöbsis,et al.  Oxidation of cerebral cytochrome aa3 by oxygen plus carbon dioxide at hyperbaric pressures. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.

[103]  J. Wettstein,et al.  White matter ischaemia , 1999, Brain Research Reviews.

[104]  R. Ridley,et al.  NXY-059, a Free Radical–Trapping Agent, Substantially Lessens the Functional Disability Resulting From Cerebral Ischemia in a Primate Species , 2001, Stroke.

[105]  G. Boysen,et al.  Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model , 1993, Journal of the Neurological Sciences.

[106]  F. Buonanno,et al.  Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. , 1997, Stroke.

[107]  M. Moskowitz,et al.  tPA and proteolysis in the neurovascular unit. , 2004, Stroke.

[108]  E. Lo,et al.  Extracellular proteolytic pathophysiology in the neurovascular unit after stroke , 2004, Neurological research.

[109]  K. Lees,et al.  Tolerability and Pharmacokinetics of the Nitrone NXY-059 in Patients With Acute Stroke , 2001, Stroke.

[110]  R. Giffard,et al.  Influence of Mild Hypothermia on Inducible Nitric Oxide Synthase Expression and Reactive Nitrogen Production in Experimental Stroke and Inflammation , 2002, The Journal of Neuroscience.

[111]  M. Chopp,et al.  Journal of Cerebral Blood Flow and Metabolism Temperature Modulation of Cerebral Depolarization during Focal Cerebral Ischemia in Rats: Correlation with Ischemic Injury , 2022 .

[112]  M. Moskowitz,et al.  Attenuated Neurotransmitter Release and Spreading Depression-Like Depolarizations after Focal Ischemia in Mutant Mice with Disrupted Type I Nitric Oxide Synthase Gene , 1998, The Journal of Neuroscience.

[113]  Sandra E. Ford,et al.  A pilot study of hyperbaric oxygen in the treatment of human stroke. , 1991, Stroke.

[114]  S. Bernard,et al.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. , 2002, The New England journal of medicine.

[115]  P. Lapchak,et al.  Effects of the Spin Trap Agent Disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) on Intracerebral Hemorrhage in a Rabbit Large Clot Embolic Stroke Model: Combination Studies With Tissue Plasminogen Activator , 2002, Stroke.

[116]  F. Barone,et al.  Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[117]  G L Wolf,et al.  Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. , 1998, AJNR. American journal of neuroradiology.

[118]  H. Diener,et al.  Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. , 2000, Stroke.

[119]  T. Wieloch,et al.  Hypothermia Prevents the Ischemia‐Induced Translocation and Inhibition of Protein Kinase C in the Rat Striatum , 1991, Journal of neurochemistry.

[120]  N. Rothwell,et al.  Role of IL-1α and IL-1β in Ischemic Brain Damage , 2001, The Journal of Neuroscience.

[121]  Profiles of glutamate and GABA efflux in core versus peripheral zones of focal cerebral ischemia in mice , 2001, Neuroscience Letters.

[122]  D. Newell,et al.  Combination Therapy with MK-801 and α-Phenyl-tert-butyl-nitrone Enhances Protection against Ischemic Neuronal Damage in Organotypic Hippocampal Slice Cultures , 1996, Experimental Neurology.

[123]  R. Auer,et al.  Eubaric hyperoxemia and experimental cerebral infarction , 2002, Annals of neurology.

[124]  J. Grotta Combination Therapy Stroke Trial: Recombinant Tissue-Type Plasminogen Activator with/without Lubeluzole , 2001, Cerebrovascular Diseases.

[125]  F. Tortella,et al.  Delayed Secondary Phase of Peri-Infarct Depolarizations after Focal Cerebral Ischemia: Relation to Infarct Growth and Neuroprotection , 2003, The Journal of Neuroscience.

[126]  P. Weinstein,et al.  Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats. , 1987, Neurosurgery.

[127]  D. Tanné,et al.  Soluble Intercellular Adhesion Molecule-1 and Risk of Future Ischemic Stroke: A Nested Case-Control Study From the Bezafibrate Infarction Prevention (BIP) Study Cohort , 2002, Stroke.

[128]  G. Boysen,et al.  Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. , 1999, Stroke.

[129]  J. Alger,et al.  Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging , 2003, Stroke.

[130]  I. Herr,et al.  CD95 Ligand (Fas-L/APO-1L) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Mediate Ischemia-Induced Apoptosis in Neurons , 1999, The Journal of Neuroscience.

[131]  K. Liu,et al.  Interstitial pO2 in Ischemic Penumbra and Core are Differentially Affected following Transient Focal Cerebral Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[132]  K. Welch Primer on cerebrovascular diseases , 1997 .

[133]  R. Morrison,et al.  bFGF enhances the protective effects of MK-801 against ischemic neuronal injury in vitro. , 1996, Neuroreport.

[134]  K. Lees,et al.  A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. , 1995, Stroke.

[135]  E. Lo,et al.  Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in Rats , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[136]  E. Mackenzie,et al.  Normobaric Hypoxia Induces Tolerance to Focal Permanent Cerebral Ischemia in Association with an Increased Expression of Hypoxia-Inducible Factor-1 and its Target Genes, Erythropoietin and VEGF, in the Adult Mouse Brain , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[137]  Junying Yuan,et al.  Apoptosis in the nervous system , 2000, Nature.

[138]  I. Ford,et al.  Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial , 2004, The Lancet.

[139]  R. Bullock,et al.  Increased inspired oxygen concentration as a factor in improved brain tissue oxygenation and tissue lactate levels after severe human head injury. , 1999, Journal of neurosurgery.

[140]  L. Goldstein,et al.  Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. , 2001, JAMA.

[141]  Weizhao Zhao,et al.  Albumin Therapy of Transient Focal Cerebral Ischemia: In Vivo Analysis of Dynamic Microvascular Responses , 2002, Stroke.

[142]  D. Krieger,et al.  Cooling for Acute Ischemic Brain Damage (COOL AID): An Open Pilot Study of Induced Hypothermia in Acute Ischemic Stroke , 2001, Stroke.

[143]  Jae-Chang Jung,et al.  Mitogen-Activated Protein Kinase Inhibition in Traumatic Brain Injury: In Vitro and In Vivo Effects , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[144]  C. Epstein,et al.  Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia , 1997, The Journal of Neuroscience.

[145]  Fuhai Li,et al.  Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. , 1997, Stroke.

[146]  H. Reulen,et al.  Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia , 1999, Brain Research.

[147]  G. Salvesen A lysosomal protease enters the death scene. , 2001, The Journal of clinical investigation.

[148]  K. Sunami,et al.  Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery , 2000, Critical care medicine.

[149]  M. Müllner,et al.  Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events , 2004, Journal of the Neurological Sciences.

[150]  D. Stein,et al.  Mild hypothermia: therapeutic window after experimental cerebral ischemia. , 1996, Neurosurgery.

[151]  R. Sacco,et al.  Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality , 2005, Neurology.

[152]  B. Kristal,et al.  An obligate role for oxygen in the early stages of glutamate-induced, delayed neuronal death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[153]  E. Tremoli,et al.  Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[154]  M. Biros,et al.  Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. , 2001, Journal of neurosurgery.

[155]  H. Diener,et al.  Organization of Stroke Care: Education, Referral, Emergency Management and Imaging, Stroke Units and Rehabilitation , 2003, Cerebrovascular Diseases.

[156]  R. Ridley,et al.  Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion. , 2003, Stroke.

[157]  M. Fisher Recommendations for Advancing Development of Acute Stroke Therapies: Stroke Therapy Academic Industry Roundtable 3 , 2003, Stroke.

[158]  M. Kirk,et al.  Hyperbaric Oxygen Therapy in Acute Ischemic Stroke: Results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study , 2003, Stroke.

[159]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[160]  A. Buchan,et al.  NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat , 2001, Brain Research.

[161]  Gary Duckwiler,et al.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging , 2000, Annals of neurology.

[162]  Effects of Acute Treatment With Pravastatin on Cerebral Vasospasm, Autoregulation, and Delayed Ischemic Deficits After Aneurysmal Subarachnoid Hemorrhage: A Phase II Randomized Placebo-Controlled Trial , 2005 .

[163]  R. Sobel,et al.  Mild Hypothermia Inhibits Nuclear Factor-κB Translocation in Experimental Stroke , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[164]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[165]  Robert M Friedlander,et al.  Apoptosis and caspases in neurodegenerative diseases. , 2003, The New England journal of medicine.

[166]  M. Ginsberg Hypothermic Neuroprotection in Cerebral Ischemia , 1997 .

[167]  M. Fisher,et al.  New perspectives on developing acute stroke therapy , 2003, Annals of neurology.

[168]  S. Warach,et al.  Rising statin use and effect on ischemic stroke outcome , 2004, BMC medicine.

[169]  S. Warach,et al.  Magnetic Resonance Imaging of Acute Stroke , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[170]  D. Atochin,et al.  Tissue Plasminogen Activator Promotes Matrix Metalloproteinase-9 Upregulation After Focal Cerebral Ischemia , 2005, Stroke.

[171]  M. Endres,et al.  Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice , 2000, Stroke.

[172]  C. Epstein,et al.  Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[173]  J. Toole,et al.  Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats , 2000, Brain Research.

[174]  Jeffrey L. Saver,et al.  Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial , 2004, Stroke.

[175]  R. Rothlein,et al.  Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy , 1995, Neurology.

[176]  R. Harbaugh,et al.  Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. , 1996, Journal of neurosurgery.

[177]  C. Prosser,et al.  COMPARATIVE ANIMAL PHYSIOLOGY , 1962 .

[178]  J. Thiran,et al.  Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients , 2002, Stroke.

[179]  R. Sacco,et al.  Tumor Necrosis Factor Receptor Levels Are Associated With Carotid Atherosclerosis , 2002, Stroke.

[180]  M. Moskowitz,et al.  Synergistic effects of caspase inhibitors and MK‐801 in brain injury after transient focal cerebral ischaemia in mice , 1998, British journal of pharmacology.

[181]  Rick M Dijkhuizen,et al.  Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke , 2002, Neurology.

[182]  P. Lapchak,et al.  Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores , 2004, Experimental Neurology.

[183]  H. Nawashiro,et al.  Preferential Conditions for and Possible Mechanisms of Induction of Ischemic Tolerance by Repeated Hyperbaric Oxygenation in Gerbil Hippocampus , 2001, Neurosurgery.

[184]  K. Furie,et al.  Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke , 2004, Stroke.

[185]  P. Lyden,et al.  Effects of hyperbaric oxygen on neurologic outcome for cerebral ischemia in rats. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[186]  S. Lipton,et al.  Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[187]  J. Ritter Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group. , 1992, Stroke.

[188]  R. Sacco,et al.  Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. , 2001, JAMA.

[189]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[190]  C. Maier,et al.  Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke , 2002, Neuroscience.

[191]  W. Hacke,et al.  Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. , 1998, Stroke.

[192]  E. Lo,et al.  Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation , 2002, Progress in Neurobiology.